John Choi Selected Research

John Choi Research Topics

Disease

20	Neoplasms (Cancer) 01/2024 - 02/2016
11	Glioma (Gliomas) 01/2024 - 01/2018
10	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 01/2019
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2019
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 12/2019
3	Brain Neoplasms (Brain Tumor) 01/2024 - 01/2019
3	Residual Neoplasm 01/2022 - 10/2019
2	Leukemia 10/2019 - 08/2014
2	Hepatitis C 01/2019 - 01/2018
2	Glaucoma 04/2007 - 01/2005
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 06/2005 - 01/2005
1	Crohn Disease (Crohn's Disease) 05/2024
1	Ulcerative Colitis 05/2024
1	Alopecia (Baldness) 04/2024
1	Ischemic Stroke 10/2023
1	Bites and Stings (Sting) 01/2023
1	Vaccinia 01/2023
1	Pain (Aches) 12/2022
1	Melanoma (Melanoma, Malignant) 02/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Exanthema (Rash) 01/2022
1	Fever (Fevers) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Hand-Foot Syndrome 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Infections 01/2020
1	Cardiomyopathies (Cardiomyopathy) 10/2019
1	Second Primary Neoplasms (Neoplasms, Second) 10/2019
1	Atlanto-Axial Fusion 03/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Gliosarcoma 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 02/2018
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Diabetes Mellitus 01/2017
1	Histiocytosis 02/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 03/2023 - 01/2023
2	Clofarabine (Clolar)FDA Link 12/2022 - 10/2019
2	Programmed Cell Death 1 ReceptorIBA 02/2022 - 01/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 10/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 02/2016
2	Etoposide (VP 16)FDA LinkGeneric 10/2019 - 01/2019
2	GuanosineIBA 01/2019 - 01/2018
2	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 01/2018
2	DorzagliatinIBA 01/2017 - 01/2016
2	GlucokinaseIBA 01/2017 - 01/2016
1	Infliximab (Remicade)FDA Link 05/2024
1	Immunologic Factors (Immunomodulators)IBA 04/2024
1	CytokinesIBA 01/2024
1	Chemokine ReceptorsIBA 01/2024
1	LigandsIBA 03/2023
1	ChemokinesIBA 03/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2022
1	Glutamic Acid (Glutamate)FDA Link 02/2022
1	LuciferasesIBA 02/2022
1	CalciumIBA 01/2022
1	Therapeutic UsesIBA 01/2021
1	HydrogelsIBA 01/2021
1	EnzymesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Thymidine KinaseIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	AntibodiesIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	ACT001IBA 01/2020
1	poly(beta-amino ester)IBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2019
1	AnthracyclinesIBA 10/2019
1	AntigensIBA 04/2019
1	recombinant human bone morphogenetic protein-2IBA 03/2019
1	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Ointments (Pastes)IBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016
1	Phosphotransferases (Kinase)IBA 02/2016

Therapy/Procedure

17	Therapeutics 01/2024 - 01/2005
9	Immunotherapy 01/2024 - 01/2018
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
1	Thrombectomy 10/2023
1	Catheters 10/2023
1	Drug Tapering 01/2022
1	Neoadjuvant Therapy 02/2021
1	Radiotherapy 01/2020
1	Cranial Irradiation 12/2019
1	Remission Induction 10/2019
1	Adjuvant Radiotherapy 01/2019
1	Transplantation 02/2018